Dantzig A H, Duckworth D C, Tabas L B
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285-0424.
Biochim Biophys Acta. 1994 Apr 20;1191(1):7-13. doi: 10.1016/0005-2736(94)90226-7.
Loracarbef, cefixime and cefuroxime axetil are beta-lactam antibiotics that are administered orally. Oral absorption of loracarbef is nearly complete, while that of cefixime and cefuroxime axetil is 30-50%. To investigate this we used the human intestinal cell line Caco-2 that possesses the proton-dependent peptide transporter that takes up cephalexin and cefaclor. Drug uptake was measured at pH 6 by high performance liquid chromatography or with radioactively labelled drug. The initial uptake rate of 1 mM cefixime was lower than that of 1 mM loracarbef. By 2 h both drugs were concentrated intracellularly against a gradient; however, the accumulation of cefixime was only 40% of that of loracarbef. The uptake rate of both drugs was sodium-independent, temperature- and energy-dependent, and was inhibited by dipeptides, cephalexin, cefaclor, but not by amino acids. Kinetic analysis of the concentration-dependence of the uptake rates for loracarbef and cefixime indicated that diffusion and a single transport system were responsible for uptake. The kinetic parameters for loracarbef and cefixime, respectively, were: Km values of 8 and 17 mM and Vmax values of 6.5 and 2 nmol/min per mg protein. Loracarbef and cefixime were competitive inhibitors of each other's uptake. By contrast, cefuroxime axetil was taken up and rapidly hydrolyzed to cefuroxime by Caco-2 cells. Cefuroxime axetil uptake was not dependent on energy and was not affected by dipeptides. Thus, cefuroxime axetil apparently enters Caco-2 cells by simple diffusion. By contrast, loracarbef and cefixime share a common transport mechanism, the proton-dependent dipeptide transporter. Cefixime was taken up less well than loracarbef due to a substantial reduction in the turnover rate and decreased affinity of the transporter for cefixime.
氯碳头孢、头孢克肟和头孢呋辛酯是口服的β-内酰胺类抗生素。氯碳头孢的口服吸收几乎是完全的,而头孢克肟和头孢呋辛酯的口服吸收为30%-50%。为了对此进行研究,我们使用了人肠细胞系Caco-2,其具有摄取头孢氨苄和头孢克洛的质子依赖性肽转运体。通过高效液相色谱法或使用放射性标记药物在pH 6条件下测量药物摄取。1 mM头孢克肟的初始摄取速率低于1 mM氯碳头孢。到2小时时,两种药物都逆浓度梯度在细胞内浓缩;然而,头孢克肟的积累量仅为氯碳头孢的40%。两种药物的摄取速率均不依赖于钠,依赖于温度和能量,并受到二肽、头孢氨苄、头孢克洛的抑制,但不受氨基酸的抑制。对氯碳头孢和头孢克肟摄取速率的浓度依赖性进行动力学分析表明,扩散和单一转运系统负责摄取。氯碳头孢和头孢克肟的动力学参数分别为:Km值为8和17 mM,Vmax值为每毫克蛋白质6.5和2 nmol/min。氯碳头孢和头孢克肟是彼此摄取的竞争性抑制剂。相比之下,头孢呋辛酯被Caco-2细胞摄取并迅速水解为头孢呋辛。头孢呋辛酯的摄取不依赖于能量,且不受二肽的影响。因此,头孢呋辛酯显然通过简单扩散进入Caco-2细胞。相比之下,氯碳头孢和头孢克肟共享一种共同的转运机制,即质子依赖性二肽转运体。由于转运体的周转率大幅降低以及对头孢克肟的亲和力下降,头孢克肟的摄取不如氯碳头孢。